Application 021829

Type: NDA
Sponsor: UCB INC

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	NEUPRO	ROTIGOTINE	FILM, EXTENDED RELEASE;TRANSDERMAL	2MG/24HR	Yes	Yes
002	NEUPRO	ROTIGOTINE	FILM, EXTENDED RELEASE;TRANSDERMAL	4MG/24HR	Yes	No
003	NEUPRO	ROTIGOTINE	FILM, EXTENDED RELEASE;TRANSDERMAL	6MG/24HR	Yes	No
004	NEUPRO	ROTIGOTINE	FILM, EXTENDED RELEASE;TRANSDERMAL	1MG/24HR	Yes	No
005	NEUPRO	ROTIGOTINE	FILM, EXTENDED RELEASE;TRANSDERMAL	3MG/24HR	Yes	No
006	NEUPRO	ROTIGOTINE	FILM, EXTENDED RELEASE;TRANSDERMAL	8MG/24HR	Yes	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 6 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N021829-001	NEUPRO	ROTIGOTINE	2MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2007-05-09
N021829-002	NEUPRO	ROTIGOTINE	4MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2007-05-09
N021829-003	NEUPRO	ROTIGOTINE	6MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2007-05-09
N021829-004	NEUPRO	ROTIGOTINE	1MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2012-04-02
N021829-005	NEUPRO	ROTIGOTINE	3MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2012-04-02
N021829-006	NEUPRO	ROTIGOTINE	8MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2012-04-02

Orange Book patents#

Current patent rows page 1 of 1 · 30 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N021829-001	8246979	2027-09-01	U-1272	Drug product	2012-09-11
N021829-001	8246979	2027-09-01	U-1273	Drug product	2012-09-11
N021829-001	10130589	2030-12-22		Drug product	2018-11-30
N021829-001	10350174	2030-12-22		Drug product	2019-07-18
N021829-001	9925150	2032-03-01		Drug product	2018-04-02
N021829-002	8246979	2027-09-01	U-1272	Drug product
N021829-002	8246979	2027-09-01	U-1273	Drug product
N021829-002	10130589	2030-12-22		Drug product	2018-11-30
N021829-002	10350174	2030-12-22		Drug product	2019-07-18
N021829-002	9925150	2032-03-01		Drug product	2018-04-02
N021829-003	8246979	2027-09-01	U-1272	Drug product
N021829-003	8246979	2027-09-01	U-1273	Drug product
N021829-003	10130589	2030-12-22		Drug product	2018-11-30
N021829-003	10350174	2030-12-22		Drug product	2019-07-18
N021829-003	9925150	2032-03-01		Drug product	2018-04-02
N021829-004	8246979	2027-09-01	U-1272	Drug product
N021829-004	8246979	2027-09-01	U-1273	Drug product
N021829-004	10130589	2030-12-22		Drug product	2018-11-30
N021829-004	10350174	2030-12-22		Drug product	2019-07-18
N021829-004	9925150	2032-03-01		Drug product	2018-04-02
N021829-005	8246979	2027-09-01	U-1272	Drug product
N021829-005	8246979	2027-09-01	U-1273	Drug product
N021829-005	10130589	2030-12-22		Drug product	2018-11-30
N021829-005	10350174	2030-12-22		Drug product	2019-07-18
N021829-005	9925150	2032-03-01		Drug product	2018-04-02
N021829-006	8246979	2027-09-01	U-1272	Drug product
N021829-006	8246979	2027-09-01	U-1273	Drug product
N021829-006	10130589	2030-12-22		Drug product	2018-11-30
N021829-006	10350174	2030-12-22		Drug product	2019-07-18
N021829-006	9925150	2032-03-01		Drug product	2018-04-02

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 7 · 246 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021829-001	NEUPRO	2MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2007-05-09	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-002	NEUPRO	4MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2007-05-09	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-003	NEUPRO	6MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2007-05-09	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-004	NEUPRO	1MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2012-04-02	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-005	NEUPRO	3MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2012-04-02	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-006	NEUPRO	8MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2012-04-02	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021829-001	NEUPRO	2MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2007-05-09	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021829-002	NEUPRO	4MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2007-05-09	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021829-003	NEUPRO	6MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2007-05-09	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021829-004	NEUPRO	1MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2012-04-02	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021829-005	NEUPRO	3MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2012-04-02	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021829-006	NEUPRO	8MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2012-04-02	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021829-001	NEUPRO	2MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2007-05-09	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021829-002	NEUPRO	4MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2007-05-09	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021829-003	NEUPRO	6MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2007-05-09	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021829-004	NEUPRO	1MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2012-04-02	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021829-005	NEUPRO	3MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2012-04-02	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021829-006	NEUPRO	8MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2012-04-02	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021829-001	NEUPRO	2MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2007-05-09	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021829-002	NEUPRO	4MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2007-05-09	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021829-003	NEUPRO	6MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2007-05-09	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021829-004	NEUPRO	1MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2012-04-02	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021829-005	NEUPRO	3MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2012-04-02	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021829-006	NEUPRO	8MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2012-04-02	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021829-001	NEUPRO	2MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2007-05-09	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021829-002	NEUPRO	4MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2007-05-09	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021829-003	NEUPRO	6MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2007-05-09	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021829-004	NEUPRO	1MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2012-04-02	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021829-005	NEUPRO	3MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2012-04-02	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021829-006	NEUPRO	8MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2012-04-02	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021829-001	NEUPRO	2MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2007-05-09	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021829-002	NEUPRO	4MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2007-05-09	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021829-003	NEUPRO	6MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2007-05-09	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021829-004	NEUPRO	1MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2012-04-02	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021829-005	NEUPRO	3MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2012-04-02	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021829-006	NEUPRO	8MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2012-04-02	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021829-001	NEUPRO	2MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2007-05-09	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021829-002	NEUPRO	4MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2007-05-09	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021829-003	NEUPRO	6MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2007-05-09	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021829-004	NEUPRO	1MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD	2012-04-02	`2680178bc6a6…`

Observed Orange Book patent history#

Patent history page 1 of 43 · 1,716 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021829-001	8246979	2027-09-01	U-1272	Drug product	2012-09-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-001	8246979	2027-09-01	U-1273	Drug product	2012-09-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-001	10130589	2030-12-22		Drug product	2018-11-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-001	10350174	2030-12-22		Drug product	2019-07-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-001	9925150	2032-03-01		Drug product	2018-04-02	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-002	8246979	2027-09-01	U-1272	Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-002	8246979	2027-09-01	U-1273	Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-002	10130589	2030-12-22		Drug product	2018-11-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-002	10350174	2030-12-22		Drug product	2019-07-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-002	9925150	2032-03-01		Drug product	2018-04-02	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-003	8246979	2027-09-01	U-1272	Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-003	8246979	2027-09-01	U-1273	Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-003	10130589	2030-12-22		Drug product	2018-11-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-003	10350174	2030-12-22		Drug product	2019-07-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-003	9925150	2032-03-01		Drug product	2018-04-02	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-004	8246979	2027-09-01	U-1272	Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-004	8246979	2027-09-01	U-1273	Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-004	10130589	2030-12-22		Drug product	2018-11-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-004	10350174	2030-12-22		Drug product	2019-07-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-004	9925150	2032-03-01		Drug product	2018-04-02	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-005	8246979	2027-09-01	U-1273	Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-005	8246979	2027-09-01	U-1272	Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-005	10130589	2030-12-22		Drug product	2018-11-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-005	10350174	2030-12-22		Drug product	2019-07-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-005	9925150	2032-03-01		Drug product	2018-04-02	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-006	8246979	2027-09-01	U-1273	Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-006	8246979	2027-09-01	U-1272	Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-006	10130589	2030-12-22		Drug product	2018-11-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-006	10350174	2030-12-22		Drug product	2019-07-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021829-006	9925150	2032-03-01		Drug product	2018-04-02	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021829-001	8246980	2025-11-27		Drug product	2012-09-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021829-001	8246979	2027-09-01	U-1272	Drug product	2012-09-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021829-001	8246979	2027-09-01	U-1273	Drug product	2012-09-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021829-001	10130589	2030-12-22		Drug product	2018-11-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021829-001	10350174	2030-12-22		Drug product	2019-07-18	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021829-001	9925150	2032-03-01		Drug product	2018-04-02	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021829-002	8246980	2025-11-27		Drug product		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021829-002	8246979	2027-09-01	U-1272	Drug product		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021829-002	8246979	2027-09-01	U-1273	Drug product		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021829-002	10130589	2030-12-22		Drug product	2018-11-30	`31067a03dcf5…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Neupro	ROTIGOTINE	UCB, Inc.	939e28c5-f3a9-42c0-9a2d-8d471d82a6e0	2025-06-24	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021829 application number: NDA021829 ndc (product): 50474-808 ndc (product): 50474-802 ndc (product): 50474-801 ndc (product): 50474-805 ndc (product): 50474-803 ndc (product): 50474-804 ndc (product): 50474-806

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 35 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
50474-801	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-801	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-801	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-801	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-801	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-802	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-802	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-802	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-802	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-802	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-803	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-803	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-803	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-803	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-803	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-804	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-804	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-804	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-804	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-804	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-805	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-805	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-805	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-805	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-805	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-806	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-806	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-806	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-806	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-806	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-808	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-808	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-808	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-808	Neupro	rotigotine	UCB, Inc.	NDA	Current
50474-808	Neupro	rotigotine	UCB, Inc.	NDA	Current

Documents#

Document, Submission type, Date table
Document	Submission type	Date
68089	SUPPL	2021-07-14
68088	SUPPL	2021-07-14
68075	SUPPL	2021-07-14
68074	SUPPL	2021-07-14
62825	SUPPL	2020-05-05
62694	SUPPL	2020-04-28
62688	SUPPL	2020-04-27
62447	SUPPL	2020-04-06
57300	SUPPL	2019-01-22
57289	SUPPL	2019-01-22
56818	SUPPL	2018-12-20
56601	SUPPL	2018-11-30
16430	SUPPL	2015-03-02
28670	SUPPL	2015-02-27
28669	SUPPL	2012-04-04
6274	SUPPL	2012-04-04
44992	SUPPL	2012-04-02
44991	SUPPL	2012-04-02
37730	SUPPL	2012-04-02
37729	SUPPL	2012-04-02
21836	ORIG	2007-07-02
28668	ORIG	2007-05-16
23076	ORIG	2007-05-10
16429	ORIG	2007-05-10